Quark Pharmaceuticals Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
70
- Latest Deal Type
-
M&A
- Financing Rounds
-
14
- Investments
-
1
Quark Pharmaceuticals General Information
Description
Developer of therapeutic Ribonucleic acid interference (RNAi) drugs based in Newark, California. The company offers services catering to the discovery and development of novel small interfering RNA (siRNA) therapeutics for renal protection in cardio-renal disease and neuroprotection in ophthalmology.
Contact Information
Website
www.quarkpharma.comCorporate Office
- 7999 Gateway Boulevard
- Suite 310
- Newark, CA 94560
- United States
Corporate Office
- 7999 Gateway Boulevard
- Suite 310
- Newark, CA 94560
- United States
Quark Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quark Pharmaceuticals Comparisons
Industry
Financing
Details
Quark Pharmaceuticals Competitors (63)
One of Quark Pharmaceuticals’s 63 competitors is X-37, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| X-37 | Venture Capital-Backed | South San Francisco, CA | ||||
| Biosplice Therapeutics | Private Equity-Backed | San Diego, CA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Numerion Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom |
Quark Pharmaceuticals Patents
Quark Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201413533-D0 | Combination therapy for treating disorders of the vestibular system | Inactive | 30-Jul-2014 | ||
| GB-201413532-D0 | Combination therapy for treating hearing disorders | Inactive | 30-Jul-2014 | ||
| GB-201413538-D0 | Ophthalmic compositions and uses thereof | Inactive | 30-Jul-2014 | ||
| GB-201413534-D0 | Otic compositions and uses thereof | Inactive | 30-Jul-2014 | ||
| AU-2015267160-A1 | Methods and compositions for preventing ischemia reperfusion injury in organs | Active | 29-May-2014 | C12N15/1135 |
Quark Pharmaceuticals Signals
Quark Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quark Pharmaceuticals Investments (1)
Quark Pharmaceuticals’s most recent deal was a Joint Venture with Kunshan RiboQuark Pharmaceutical Technology. The deal was made on 01-Sep-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kunshan RiboQuark Pharmaceutical Technology | 01-Sep-2012 | Joint Venture | Drug Discovery |
Quark Pharmaceuticals FAQs
-
When was Quark Pharmaceuticals founded?
Quark Pharmaceuticals was founded in 1994.
-
Where is Quark Pharmaceuticals headquartered?
Quark Pharmaceuticals is headquartered in Newark, CA.
-
What is the size of Quark Pharmaceuticals?
Quark Pharmaceuticals has 70 total employees.
-
What industry is Quark Pharmaceuticals in?
Quark Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Quark Pharmaceuticals a private or public company?
Quark Pharmaceuticals is a Private company.
-
What is Quark Pharmaceuticals’s current revenue?
The current revenue for Quark Pharmaceuticals is .
-
How much funding has Quark Pharmaceuticals raised over time?
Quark Pharmaceuticals has raised $117M.
-
Who are Quark Pharmaceuticals’s investors?
Astellas Pharma, Astex Pharmaceuticals, Concordia Capital Partners, Daiichi Sankyo, and GoAhead Ventures are 5 of 13 investors who have invested in Quark Pharmaceuticals.
-
Who are Quark Pharmaceuticals’s competitors?
X-37, Biosplice Therapeutics, Voyager Therapeutics, Numerion Labs, and Exscientia are some of the 63 competitors of Quark Pharmaceuticals.
-
When was Quark Pharmaceuticals acquired?
Quark Pharmaceuticals was acquired on 01-May-2021.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process